#APHINITY
LightNews LightNews
mblade.ca
Was this Aphinity flying?
November 4, 2026 at 4:01 AM
nthercyte.bsky.social
new music with Aphinity "Hyperia 2006". Take a listen on any platform you listen music.
October 16, 2026 at 10:02 AM
nthercyte.bsky.social
soundcloud.com/nthercyte/hy...
Hyperia 2006
A collaboration music between Nthercyte and Aphinity inspired by rhythm game style of music. Follow Nthercyte: https://linktr.ee/nthercyte Follow Aphinity: https://linktr.ee/aphinity
soundcloud.com
October 16, 2026 at 10:02 AM
newsen.bsky.social
Rochester Midland Corporation Expands Capabilities with ApHinity Technologies Acquisition#United_States#Rochester#Water_Treatment#Rochester_Midland#ApHinity_Technologies
Rochester Midland Corporation Expands Capabilities with ApHinity Technologies Acquisition
Rochester Midland Corporation enhances its offerings through the acquisition of ApHinity Technologies, a leader in environmental solutions focused on water and air quality optimization.
third-news.com
October 12, 2026 at 12:06 PM
abangelabs.bsky.social
TLV has added subcutaneous Phesgo to Sweden's benefits scheme for early and metastatic HER2+ breast cancer, leaning on APHINITY and CLEOPATRA. https://www.mattheneus.com/editorial/tlv-phesgo-subcutaneous-her2-breast-cancer-benefits-inclusion-aphinity-cleopatra-2026-09-30 #HTA #HealthEconomics
September 30, 2026 at 12:02 PM
oncoalert.bsky.social
The OncoAlert🚨Newsletter Covering April 3-9, 2026
REGISTER TO GET IT 👉 buff.ly/7Jlzp0V or oncoalert360.com

Breast Cancer
🧬 TROPION-Breast02
🧬 APHINITY

GU Cancers
🧬 CALYPSO
🧬 IMDC Real-World Analysis

Lung Cancer
🧬 LungIMPACT
and much more
April 9, 2026 at 9:07 AM
oncoalert.bsky.social
The benefit of adjuvant pertuzumab and trastuzumab according to estrogen receptor and HER2 expression: a Sub-analysis of the APHINITY trial

academic.oup.com/jnci/advance...

Adding pertuzumab to trastuzumab and chemotherapy🧪 improved invasive DFS across biomarker-defined subgroups
April 8, 2026 at 9:55 AM
oncoalert.bsky.social
The VJ OA Oncology Journal Club
Dr. Evandro de Azambuja discussing APHINITY in #BreastCancer now on APPLE PODCASTS

podcasts.apple.com/se/podcast/o...

@elisaagostinetto.bsky.social
@elisabettabonzano.bsky.social
@icromeattini.bsky.social
@maryamlustberg.bsky.social
VJ OA Oncology Journal Club: Final Results of the APHINITY Breast Cancer Trial Presented at ESMO Breast 2025
Poddavsnitt · OncoAlert · 2025-05-16 · 3 min
podcasts.apple.com
May 22, 2025 at 11:16 AM
oncoalert.bsky.social
The @OncoAlert 🚨 @VJOncology JOURNAL CLUB
Today we present @E_de_Azambuja 🇧🇪of @JulesBordet who talks to us about the Final Analysis of the APHINITY trial just Presented at #ESMOBreast25
youtu.be/ydcXe_faQH0

A sub analysis was just published out on European Journal of Cancer:
VJ OA Oncology Journal Club: Final Results of the APHINITY Breast Cancer Trial Presented at ESMO ...
Dr. Evandro de Azambuja discusses the final analysis of the APHINITY Breast Cancer trial just presented at ESMO Breast 2025.
youtu.be
May 16, 2025 at 10:13 AM
ultravioletriotart.bsky.social
Neon badges for Kahyu and Aphinity!

https://linktr.ee/UltraVioletRiotArt
🚫 Do not trace, repost, or edit.
April 9, 2026 at 1:24 AM
brycehaymond.bsky.social
...Extrapolation from the results of the adjuvant APHINITY trial suggest that continuing pertuzumab [Perjeta] in the adjuvant setting is beneficial only in node-positive disease."

pmc.ncbi.nlm.nih.gov/articles/PMC...
December 22, 2024 at 8:34 PM
brycehaymond.bsky.social
completely ignoring the industry standard of care & clinical guidelines, probably because it's very expensive & so it's not good for bottom line profits.

#MedicareForAll #Medicare4All #healthinsurance #insurancedenial #perjeta #BreastCancer #HealthcareJustice #PatientAdvocacy #aphinity #healthcare
December 20, 2024 at 2:06 PM
brycehaymond.bsky.social
based on the APHINITY trial results. NICE is another government org in England/UK that approved it in at least 2019, if not earlier.

It is the private insurer Regence BlueCross BlueShield of Utah @regenceutah.bsky.social that is still denying it today on arbitrary and capricious grounds...
December 20, 2024 at 2:06 PM
brycehaymond.bsky.social
based on a single clinical trial (APHINITY) that found precisely the opposite, that the drug is clearly beneficial in reducing recurrence risk and increasing overall survival for Raven's type of cancer, and which is the very reason the FDA, NCCN, ASCO, and NICE all recommend it...
December 15, 2024 at 5:05 PM
brycehaymond.bsky.social
Insurance claims that since the APHINITY trial explored its benefits in the adjuvant phase, excluding patients who received it in the neoadjuvant phase, that its benefits are "not known" and therefore "investigational" for those patients. Of course, that is pure BS.
www.facebook.com/share/p/189f...
Redirecting...
www.facebook.com
December 11, 2024 at 10:47 PM
oncodaily.bsky.social
Final Overall Survival Results from the APHINITY Trial Confirm Long-Term Benefit of Adjuvant Pertuzumab in Early HER2-Positive Breast Cancer

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #OS #APHINITY #Pertuzumab #BreastCancer #HER2
Final Overall Survival Results from the APHINITY Trial Confirm Long-Term Benefit of Adjuvant Pertuzumab in Early HER2-Positive Breast Cancer - OncoDaily
Final Overall Survival Results from the APHINITY Trial Confirm Long-Term Benefit of Adjuvant Pertuzumab in Early HER2-Positive Breast Cancer / APHINITY trial,
oncodaily.com
May 15, 2025 at 10:38 PM
millenniumstrike.bsky.social
Set Times for today (cdt):

Pre-Lobby - 3:30pm
Starts - 4:00pm

here in heaven - 4:10pm
Aphinity - 4:45pm
Special Mages Guild Segment - 5:20pm
zweihänder - 5:35pm
BLK CRX x Plead The Filth - 6:45pm
Ghozt + VJ Skull System - 7:25pm
MMIC - 8:05pm
GODSHOULDHAVEKNOWN - 8:45pm
October 24, 2025 at 1:48 PM
millenniumstrike.bsky.social
linktr.ee/aphinity
Aphinity | Twitter, Instagram | Linktree
View aphinity’s Linktree to discover and stream music from top platforms like Spotify here. Your next favorite track is just a click away!
linktr.ee
October 9, 2025 at 8:50 PM
launches.uicomet.com
→ Aphinity
Smart 1:1 member intros to boost engagement in your community

#product

https://www.aphinity.ai/
February 14, 2026 at 4:28 PM
elisaagostinetto.bsky.social
Right before the start of #ESMOBreast25, our last article is now out in #EJC

In this sub-analysis of the APHINITY trial led by @ChiaraDauccia, overweight/obesity was associated with poorer survival outcomes

50-days free access link👇🏻
authors.elsevier.com/a/1l5DL3QE--...

@oncoalert.bsky.social
authors.elsevier.com
May 13, 2025 at 7:00 PM
sydneyroo.bsky.social
That belongs to Aphinity!
July 20, 2025 at 12:21 AM
vanhooverpe.bsky.social
Oh sorry, that's correct - I was just looking into who drew the first one then I remembered you sent it to Aphinity who printed it out for us - thank you again!
January 28, 2026 at 8:25 PM
blueresearch.bsky.social
Genentech announces final overall survival results from APHINITY study
Reported Tuesday, May 13 - 5:44am EDT (TheFly subscription required to read more.)
thefly.com
May 13, 2025 at 9:51 AM
breastcancerorg.bsky.social
🚨 #APHINITY Trial • #ESMOBreast25🚨 Pertuzumab (Perjeta) + trastuzumab (Herceptin) + chemo significantly improves long-term survival for people with HER2-positive early-stage breast cancer, especially those with lymph node involvement or hormone receptor–positive tumors. Read more 🔗 bit.ly/ESMO2025
May 17, 2025 at 1:48 AM
neoboy.bsky.social
H O P E
Ninajirachi & Porter Robinson - WannaCry (Aphinity Hypertrance Bootleg)
YouTube video by Aphinity
youtu.be
August 17, 2026 at 11:01 PM